Search research articles
Contact Us
Filters
Showing results (61-70 of 215) with videos related to
Page
of 22
Sort By:
British Journal of Haematology
|
October 30, 2016
A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasia
Amer M Zeidan, B Douglas Smith, Hetty E Carraway, et al.
Haematologica
|
November 22, 2011
Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromes
Sheila Weiss Smith, Masayo Sato, Steven D Gore, et al.
Leukemia & Lymphoma
|
July 26, 2017
Clinical evaluation of combined azacitidine and entinostat on the induction of fetal hemoglobin in patients with acute myeloid leukemias and myelodysplastic syndromes
Katharine R Press, Natalie Uy, Jeffrey Keefer, et al.
Cancer
|
August 1, 2017
A call for action: Increasing enrollment of untreated patients with higher-risk myelodysplastic syndromes in first-line clinical trials
Amer M Zeidan, Maximilian Stahl, Mikkael A Sekeres, et al.
Journal of Medicinal Chemistry
|
September 30, 2005
Alkyl-substituted polyaminohydroxamic acids: a novel class of targeted histone deacetylase inhibitors
Sheeba Varghese, Deepak Gupta, Tiffany Baran, et al.
Leukemia Research
|
March 26, 2013
Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelines
Amy J Davidoff, Sheila R Weiss, Maria R Baer, et al.
Leukemia Research
|
February 10, 2020
Disseminated, yet dissembled: Rare infections behind the veil of classical hairy cell leukemia
Rory M Shallis, Timil H Patel, Nikolai A Podoltsev, et al.
Blood Cancer Discovery
|
November 15, 2021
How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies
Antoni Ribas, Madhav V Dhodapkar, Katie M Campbell, et al.
Biomedical Chromatography : BMC
|
November 30, 2021
Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax
Susan C Scott, Nicole M Anders, Ping He, et al.
Annals of Hematology
|
October 23, 2021
Molecular testing of isolated myeloid sarcoma allows successful FLT3-targeted therapy
Rory M Shallis, Darko Pucar, Sudhir Perincheri, et al.
Page
of 22
Search research articles
Search
Showing results (61-70 of 215) with videos related to
Sort By:
Page
of 22
British Journal of Haematology
|
October 30, 2016
A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasia
Amer M Zeidan, B Douglas Smith, Hetty E Carraway, et al.
Haematologica
|
November 22, 2011
Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromes
Sheila Weiss Smith, Masayo Sato, Steven D Gore, et al.
Leukemia & Lymphoma
|
July 26, 2017
Clinical evaluation of combined azacitidine and entinostat on the induction of fetal hemoglobin in patients with acute myeloid leukemias and myelodysplastic syndromes
Katharine R Press, Natalie Uy, Jeffrey Keefer, et al.
Cancer
|
August 1, 2017
A call for action: Increasing enrollment of untreated patients with higher-risk myelodysplastic syndromes in first-line clinical trials
Amer M Zeidan, Maximilian Stahl, Mikkael A Sekeres, et al.
Journal of Medicinal Chemistry
|
September 30, 2005
Alkyl-substituted polyaminohydroxamic acids: a novel class of targeted histone deacetylase inhibitors
Sheeba Varghese, Deepak Gupta, Tiffany Baran, et al.
Leukemia Research
|
March 26, 2013
Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelines
Amy J Davidoff, Sheila R Weiss, Maria R Baer, et al.
Leukemia Research
|
February 10, 2020
Disseminated, yet dissembled: Rare infections behind the veil of classical hairy cell leukemia
Rory M Shallis, Timil H Patel, Nikolai A Podoltsev, et al.
Blood Cancer Discovery
|
November 15, 2021
How to Provide the Needed Protection from COVID-19 to Patients with Hematologic Malignancies
Antoni Ribas, Madhav V Dhodapkar, Katie M Campbell, et al.
Biomedical Chromatography : BMC
|
November 30, 2021
Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax
Susan C Scott, Nicole M Anders, Ping He, et al.
Annals of Hematology
|
October 23, 2021
Molecular testing of isolated myeloid sarcoma allows successful FLT3-targeted therapy
Rory M Shallis, Darko Pucar, Sudhir Perincheri, et al.
Page
of 22